A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder

Clinical trial NCT00170755 · COMPLETED

Trial details

NCT number: NCT00170755
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Overactive Bladder Syndrome

Start date: 2002-04-01
Enrollment: 718

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.